Clinical trials in cancer
2011
Clinical Trials in Cancer
Editorial
Author Information
Author(s): Green J A
Primary Institution: University of Liverpool
Conclusion
The investment in clinical trials in the UK has led to increased recruitment and a stimulated research ethos, although the overall impact on cancer survival remains unclear.
Supporting Evidence
- The UK initiative has successfully doubled recruitment to clinical trials to 7.5% of incident cancer cases.
- 50% of NHS Trusts achieved a 10% target for trial recruitment.
- There has been a reduction in the number of trials failing to meet their target.
Takeaway
This article talks about how clinical trials for cancer have improved in the UK, helping more people get involved, but it's still hard to say if this has made cancer survival better.
Limitations
The article notes challenges in proving cause and effect regarding cancer survival improvements and highlights bureaucratic delays in trial processes.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website